<div id="readability-page-1"><h3>Claim 55% Off TipRanks</h3><ul><li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions </li><li> Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks </li></ul>HCA Healthcare ( (HCA) ) just unveiled an announcement. On April 30, 2026, HCA Inc., a wholly owned subsidiary of HCA Healthcare, completed a $3 billion public offering of senior unsecured notes, comprising $1 billion of 4.700% notes due 2031, $750 million of 5.000% notes due 2033 and $1.25 billion of 5.300% notes due 2036, all fully and unconditionally guaranteed by HCA Healthcare. The notes, issued under an existing base indenture and new supplemental indentures following an underwriting agreement signed on April 27, 2026, rank as senior unsecured obligations with customary covenants, optional redemption features, and change-of-control repurchase rights, further diversifying the group’s long-term funding and potentially strengthening its balance sheet and financial flexibility. The instruments carry semi-annual interest payments starting November 15, 2026, and include provisions that limit certain liens, sale-leaseback transactions and major corporate restructurings by HCA Inc. and HCA Healthcare. These terms, along with defined events of default and ratings-based change-of-control protections, are designed to balance lender protections with the issuer’s operational flexibility, shaping the group’s capital structure and risk profile for the coming decade. The most recent analyst rating on (HCA) stock is a Hold with a $503.00 price target. To see the full list of analyst forecasts on HCA Healthcare stock, see the HCA Stock Forecast page. Spark’s Take on HCA Stock According to Spark, TipRanks’ AI Analyst, HCA is a Neutral. The score is supported by resilient profitability and strong cash generation plus reaffirmed guidance and continued capital returns. It is held back primarily by elevated balance-sheet risk (persistent negative equity) and clearly weak technical momentum (price below key moving averages with negative MACD and very low RSI). Valuation is reasonable but the low dividend yield offers limited additional support. To see Spark’s full report on HCA stock, click here. More about HCA Healthcare HCA Healthcare, through its wholly owned subsidiary HCA Inc., operates in the healthcare services industry as a major hospital and clinical care provider in the United States. The company regularly accesses U.S. capital markets to finance its operations and capital investments, using senior unsecured notes and other debt securities issued under shelf registration statements. Average Trading Volume: 1,101,881 Technical Sentiment Signal: Buy Current Market Cap: $96.73B See more data about HCA stock on TipRanks’ Stock Analysis page.</div>

HCA Healthcare has completed a $3 billion public offering of senior unsecured notes, including $1 billion of 4.700% notes due 2031, $750 million of 5.000% notes due 2033, and $1.25 billion of 5.300% notes due 2036. The offering aims to diversify long-term funding and enhance financial flexibility. The notes will have semi-annual interest payments starting November 15, 2026, and include provisions for lender protections and operational flexibility. Analysts currently rate HCA stock as a Hold with a price target of $503.00, citing resilient profitability but elevated balance-sheet risk.

Tip Ranks

HCA Healthcare

VG Health

HCA Healthcare Completes $3 Billion Senior Notes Offering